$ACRE
Ares Commercial Real Estate Corp Stock $acre

$acre Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000110465913060683 Filed on August 07, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$6.207M	$1.560M
YoY Change	297.88%
Cost Of Revenue	$2.520M	$770.0K
YoY Change	227.27%
Gross Profit	$5.570M	$790.0K
YoY Change	605.06%
Gross Profit Margin	89.74%	50.64%
Selling, General & Admin	$1.820M	$960.0K
YoY Change	89.58%
% of Gross Profit	32.68%	121.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.820M	$960.0K
YoY Change	89.58%
Operating Profit	$3.750M	-$170.0K
YoY Change	-2305.88%
Interest Expense	$640.0K	$0.00
YoY Change
% of Operating Profit	17.07%
Other Income/Expense, Net
YoY Change
Pretax Income	$3.265M	-$180.0K
YoY Change	-1913.89%
Income Tax	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$3.265M	-$175.0K
YoY Change	-1965.71%
Net Earnings / Revenue	52.6%	-11.22%
Basic Earnings Per Share
Diluted Earnings Per Share	$93.80K	-$27.36K
COMMON SHARES
Basic Shares Outstanding	10.22M shares	6.577M shares
Diluted Shares Outstanding	10.26M shares	6.577M shares

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$40.20M	$87.50M
YoY Change	-54.06%
Cash & Equivalents	$40.24M	$87.46M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$3.300M	$600.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$43.50M	$88.10M
YoY Change	-50.62%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$526.0M	$78.20M
YoY Change	572.63%
Other Assets	$9.200M	$4.300M
YoY Change	113.95%
Total Long-Term Assets	$537.6M	$83.16M
YoY Change	546.42%
TOTAL ASSETS
Total Short-Term Assets	$43.50M	$88.10M
Total Long-Term Assets	$537.6M	$83.16M
Total Assets	$581.1M	$171.3M
YoY Change	239.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$0.00
YoY Change
Accrued Expenses		$800.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.70M	$2.200M
YoY Change	431.82%
LONG-TERM LIABILITIES
Long-Term Debt	$168.8M	$0.00
YoY Change
Other Long-Term Liabilities	$5.600M	$1.300M
YoY Change	330.77%
Total Long-Term Liabilities	$174.4M	$1.300M
YoY Change	13315.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.70M	$2.200M
Total Long-Term Liabilities	$174.4M	$1.300M
Total Liabilities	$186.2M	$3.601M
YoY Change	5070.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.401M
YoY Change
Common Stock	$404.3M	$92.00K
YoY Change	439331.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$394.9M	$167.7M
YoY Change
Total Liabilities & Shareholders Equity	$581.1M	$171.3M
YoY Change	239.29%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	$3.265M	-$175.0K
YoY Change	-1965.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$800.0K	-$500.0K
YoY Change	-260.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$100.0K
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$116.5M	-$900.0K
YoY Change	12844.44%
Cash From Investing Activities	-$116.5M	-$1.000M
YoY Change	11550.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$234.6M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	133.5M	84.30M
YoY Change	58.36%
NET CHANGE
Cash From Operating Activities	800.0K	-500.0K
Cash From Investing Activities	-116.5M	-1.000M
Cash From Financing Activities	133.5M	84.30M
Net Change In Cash	17.80M	82.80M
YoY Change	-78.5%
FREE CASH FLOW
Cash From Operating Activities	$800.0K	-$500.0K
Capital Expenditures	$0.00	-$100.0K
Free Cash Flow	$800.0K	-$400.0K
YoY Change	-300.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	acre	Impairments Of Loans Held For Investment ImpairmentsOfLoansHeldForInvestment	0	USD
CY2012	acre	Impairments Of Loans Held For Investment ImpairmentsOfLoansHeldForInvestment	0	USD
	acre	Number Of Subsequent Taxable Years Subject To Disqualification NumberOfSubsequentTaxableYearsSubjectToDisqualification	P4Y
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	item
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Concentration of Credit Risk</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents and loans held for investment. The Company places its cash and cash equivalents with financial institutions and, at times, cash held may exceed the Federal Deposit Insurance Corporation, or “FDIC”, insured limit. The Company has exposure to credit risk on its CRE loans and other target investments. The Company’s Manager will seek to manage credit risk by performing credit fundamental analysis of potential collateral assets.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"> </p> </div>
CY2012Q2	us-gaap	Share Price SharePrice	18.50
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	54516	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3787747	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9764941	shares
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.37
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates in the Preparation of Financial Statements</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of derivatives.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"> </p> </div>
	us-gaap	Mortgage Loans On Real Estate Number Of Loans MortgageLoansOnRealEstateNumberOfLoans	21	item
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	186402000	USD
	us-gaap	Mortgage Loans On Real Estate Collections Of Principal MortgageLoansOnRealEstateCollectionsOfPrincipal	13500000	USD
CY2013Q2	us-gaap	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	529739000	USD
CY2013Q2	acre	Mortgage Loans On Real Estate Total Commitment Amount MortgageLoansOnRealEstateTotalCommitmentAmount	589400000	USD
CY2013Q2	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	525994000	USD
	acre	Mortgage Loans On Real Estate Unleveraged Effective Yield MortgageLoansOnRealEstateUnleveragedEffectiveYield	0.068	pure
	us-gaap	Mortgage Loans On Real Estate New Mortgage Loans MortgageLoansOnRealEstateNewMortgageLoans	171402000	USD
	acre	Mortgage Loans On Real Estate Receipt Of Origination Fee MortgageLoansOnRealEstateReceiptOfOriginationFee	1664000	USD
	us-gaap	Mortgage Loans On Real Estate Other Additions MortgageLoansOnRealEstateOtherAdditions	15000000	USD
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	1268000	USD
CY2013Q2	us-gaap	Line Of Credit LineOfCredit	101285000	USD
CY2013Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	361225000	USD
CY2012Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	308725000	USD
CY2012Q4	us-gaap	Line Of Credit LineOfCredit	144256000	USD
CY2013Q2	acre	Commitments Commitments	589395000	USD
CY2012Q4	acre	Commitments Commitments	405695000	USD
CY2013Q2	acre	Funded Commitments FundedCommitments	529932000	USD
CY2012Q4	acre	Funded Commitments FundedCommitments	356930000	USD
CY2013Q2	acre	Unfunded Commitments UnfundedCommitments	59463000	USD
CY2012Q4	acre	Unfunded Commitments UnfundedCommitments	48765000	USD
CY2012Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	95000000	shares
CY2012Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2012Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	7700000	shares
CY2012Q2	acre	Gross Proceeds From Issuance Of Shares In Initial Public Offering GrossProceedsFromIssuanceOfSharesInInitialPublicOffering	142500000	USD
CY2012Q2	acre	Adjustments To Additional Paid In Capital Stock Issued Underwriting Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedUnderwritingCosts	-5300000	USD
CY2012Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3500000	USD
CY2012Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	139000000	USD
CY2012Q2	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	47300000	USD
CY2012Q2	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock	6300000	USD
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	690000	shares
CY2012	acre	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Issued And Outstanding Common Stock Eligible ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfIssuedAndOutstandingCommonStockEligible	0.075	pure
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	59911	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	14212	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	2919	shares
CY2012Q4	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Next Twelve Months ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInNextTwelveMonths	17309	shares
CY2012Q4	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Two ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearTwo	25018	shares
CY2012Q4	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Three ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearThree	12088	shares
CY2012Q4	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest In Year Four ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestInYearFour	5520	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10215782	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10257250	shares
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.32
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-225000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-341000	USD
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6576923	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6576923	shares
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3787747	shares
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3592000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9720477	shares
CY2013Q2	us-gaap	Interest Expense Other InterestExpenseOther	1499000	USD
CY2012Q2	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.11
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.50
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
	us-gaap	Dividends Cash DividendsCash	9139000	USD
	us-gaap	Dividends Cash DividendsCash	1005000	USD
CY2012Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1500000	shares
CY2012Q1	us-gaap	Dividends Cash DividendsCash	450000	USD
	dei	Entity Registrant Name EntityRegistrantName	Ares Commercial Real Estate Corp
	dei	Entity Central Index Key EntityCentralIndexKey	0001529377
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	165438000	USD
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23390000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3210000	USD
CY2012Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	353500000	USD
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1746000	USD
CY2012Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5168000	USD
CY2012Q4	us-gaap	Other Assets OtherAssets	845000	USD
CY2012Q4	us-gaap	Assets Assets	387859000	USD
CY2013Q2	us-gaap	Assets Assets	581059000	USD
CY2013Q2	us-gaap	Liabilities Liabilities	186183000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	394876000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	581059000	USD
CY2013Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6207000	USD
CY2012Q4	us-gaap	Unsecured Debt UnsecuredDebt	67289000	USD
CY2012Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1825000	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1788000	USD
CY2012Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1320000	USD
CY2012Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2316000	USD
CY2012Q4	us-gaap	Other Liabilities OtherLiabilities	3627000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	222421000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	92000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	169200000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3854000	USD
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27888359	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	387859000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27286769	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27286769	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9267162	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9267162	shares
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	11533000	USD
CY2013Q2	us-gaap	Noninterest Expense NoninterestExpense	5079000	USD
	us-gaap	Noninterest Expense NoninterestExpense	9680000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	3265000	USD
	us-gaap	Net Income Loss NetIncomeLoss	3592000	USD
CY2012Q2	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	1559000	USD
CY2012Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	353000	USD
CY2012Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1206000	USD
	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	2508000	USD
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	692000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1816000	USD
CY2012Q2	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	419000	USD
CY2012Q2	us-gaap	Professional Fees ProfessionalFees	331000	USD
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	323000	USD
CY2012Q2	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	308000	USD
CY2012Q2	us-gaap	Noninterest Expense NoninterestExpense	1381000	USD
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	419000	USD
	us-gaap	Professional Fees ProfessionalFees	414000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	331000	USD
	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	319000	USD
	us-gaap	Noninterest Expense NoninterestExpense	1483000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-175000	USD
	us-gaap	Net Income Loss NetIncomeLoss	333000	USD
CY2012Q2	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	50000	USD
	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	102000	USD
	us-gaap	Temporary Equity Accretion Of Dividends TemporaryEquityAccretionOfDividends	-572000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.11
CY2012Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.06
	us-gaap	Interest Expense Other InterestExpenseOther	3050000	USD
CY2013Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1121000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1761000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	453000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2020000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-172226000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	187051000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	16845000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	265000	USD
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	138000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	67000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	577000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1434000	USD
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	573000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-200000	USD
	acre	Increase Decrease In Accrued Expenses And Other Liabilities IncreaseDecreaseInAccruedExpensesAndOtherLiabilities	405000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-706000	USD
	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	73164000	USD
	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	74000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	62000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-73152000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	47277000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1637000	USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	5723000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	165850000	USD
	us-gaap	Payments For Repurchase Of Convertible Preferred Stock PaymentsForRepurchaseOfConvertiblePreferredStock	6295000	USD
	acre	Pre Ipo Common Dividend Payment PreIPOCommonDividendPayment	450000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	102000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	160073000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	86215000	USD
	us-gaap	Interest Paid Net InterestPaidNet	426000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1739000	USD
	us-gaap	Proceeds From Loan And Lease Originations And Principal Collections1 ProceedsFromLoanAndLeaseOriginationsAndPrincipalCollections1	1664000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4634000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1240000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	87455000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40235000	USD
CY2012Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	555000	USD
CY2013Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2012Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	379000	USD
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	18000000	shares
CY2013Q2	us-gaap	Share Price SharePrice	13.50
CY2013Q2	acre	Gross Proceeds From Issuance Of Shares In Public Offering GrossProceedsFromIssuanceOfSharesInPublicOffering	243000000	USD
CY2013Q2	acre	Underwriters Option To Purchase Additional Common Stock Shares Number UnderwritersOptionToPurchaseAdditionalCommonStockSharesNumber	2700000	shares
	acre	Mortgage Loans On Real Estate Loan Paid Off MortgageLoansOnRealEstateLoanPaidOff	-13400000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	235000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	47277000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	138137000	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	3016000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1566000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	235000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	166000	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	8336000	USD
	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	243000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	490000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	22526	shares
CY2013Q2	acre	Mortgage Loans On Real Estate Impairment Charges Recognized MortgageLoansOnRealEstateImpairmentChargesRecognized	0	USD
CY2012Q4	acre	Mortgage Loans On Real Estate Impairment Charges Recognized MortgageLoansOnRealEstateImpairmentChargesRecognized	0	USD
CY2013Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2137000	USD
CY2013Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	8300000	USD
CY2013Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	234700000	USD
CY2013Q2	acre	Percentage In Excess Of Outstanding Shares For Which Entity Obtained Stockholder Approval To Issue Shares PercentageInExcessOfOutstandingSharesForWhichEntityObtainedStockholderApprovalToIssueShares	0.20	pure
CY2013Q2	acre	Conversion Options Cumulative Value Reclassified To Additional Paid In Capital ConversionOptionsCumulativeValueReclassifiedToAdditionalPaidInCapital	86000	USD
CY2013Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	18000000	shares
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4670000	USD
CY2013Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	3312000	USD
CY2013Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4546000	USD
CY2013Q2	us-gaap	Other Assets OtherAssets	2302000	USD
CY2013Q2	us-gaap	Unsecured Debt UnsecuredDebt	67535000	USD
CY2013Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	3346000	USD
CY2013Q2	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1563000	USD
CY2013Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	6822000	USD
CY2013Q2	us-gaap	Other Liabilities OtherLiabilities	5632000	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	272000	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	404005000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9401000	USD
CY2013Q2	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	8086000	USD
CY2013Q2	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	1879000	USD
	us-gaap	Interest And Fee Income Loans And Leases Held In Portfolio InterestAndFeeIncomeLoansAndLeasesHeldInPortfolio	14798000	USD
	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	3265000	USD
CY2013Q2	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	643000	USD
CY2013Q2	us-gaap	Professional Fees ProfessionalFees	500000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	453000	USD
CY2013Q2	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	863000	USD
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1256000	USD
	us-gaap	Professional Fees ProfessionalFees	1067000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	936000	USD
	acre	General And Administrative Expenses Reimbursed To Affiliate GeneralAndAdministrativeExpensesReimbursedToAffiliate	1610000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
	acre	Increase Decrease In Accrued Expenses And Other Liabilities IncreaseDecreaseInAccruedExpensesAndOtherLiabilities	1374000	USD
	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	13512000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	95165000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	202000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	243000000	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	8141000	USD
	us-gaap	Interest Paid Net InterestPaidNet	5188000	USD
CY2013Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	715000	USD
CY2012Q4	acre	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Grants To Date ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingGrantsToDate	59935	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	243000000	USD
CY2013Q2	acre	Mortgage Loans On Real Estate Number Of Loans Repaid MortgageLoansOnRealEstateNumberOfLoansRepaid	1	item
CY2013Q2	acre	Mortgage Loans On Real Estate Unleveraged Effective Yield Dispositions And Early Prepayments Or Defaults MortgageLoansOnRealEstateUnleveragedEffectiveYieldDispositionsAndEarlyPrepaymentsOrDefaults	0	USD
	acre	Mortgage Loans On Real Estate Amortizing Payments MortgageLoansOnRealEstateAmortizingPayments	-112000	USD
	acre	Percentage Of Common Stock For Which Entity Has Option To Issue PercentageOfCommonStockForWhichEntityHasOptionToIssue	1.00	pure
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	86000	USD
CY2012Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.30

Files In Submission

Name	View Source	Status
0001104659-13-060683-index-headers.html	Edgar Link	pending
0001104659-13-060683-index.html	Edgar Link	pending
0001104659-13-060683.txt	Edgar Link	pending
0001104659-13-060683-xbrl.zip	Edgar Link	pending
a13-13948_110q.htm	Edgar Link	pending
a13-13948_1ex31d1.htm	Edgar Link	pending
a13-13948_1ex31d2.htm	Edgar Link	pending
a13-13948_1ex31d3.htm	Edgar Link	pending
a13-13948_1ex32d1.htm	Edgar Link	pending
acre-20130630.xml	Edgar Link	completed
acre-20130630.xsd	Edgar Link	pending
acre-20130630_cal.xml	Edgar Link	unprocessable
acre-20130630_def.xml	Edgar Link	unprocessable
acre-20130630_lab.xml	Edgar Link	unprocessable
acre-20130630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACRE
Ares Commercial Real Estate Corp Stock $acre

2013 Q2 Form 10-Q Financial Statement

#000110465913060683 Filed on August 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACRE Ares Commercial Real Estate Corp Stock $acre

2013 Q2 Form 10-Q Financial Statement

#000110465913060683 Filed on August 07, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACRE
Ares Commercial Real Estate Corp Stock $acre